Our Lab is focused on advancing our understanding of cancer biology, particularly in the realm of cellular metabolism and signal transduction. Central to our research is the study of the PI3K pathway, a key regulator in cell growth and survival, and its role in cancer development and progression. Our mission encompasses a multifaceted approach:
Elucidating the PI3K Pathway: We aim to dissect the complexities of the PI3K pathway, understanding its function in normal cells and how its dysregulation contributes to cancer.
Investigating Metabolic Dependencies: By identifying the unique metabolic needs of cancer cells, our research seeks to uncover potential therapeutic vulnerabilities across various cancer types.
Overcoming Drug Resistance: A significant portion of our work is dedicated to unraveling the mechanisms behind cancer drug resistance and tumor progression, aiming to enhance the efficacy of current treatments.
Translational Impact: Bridging laboratory discoveries with clinical applications is a key objective. We strive to translate our findings into novel, effective treatment strategies that can be evaluated in clinical trials.
Our lab is committed to pushing the boundaries of cancer research, fostering collaborations, and nurturing the next generation of scientists. Through our work, we aim to make significant contributions that will lead to improved cancer treatments and patient outcomes.